Food and Drug Administration (FDA) approved Rybelsus in September 2019 as the first oral GLP-1 receptor agonist for adults with type 2 diabetes
Comparable Efficacy Despite being an oral medication, Rybelsus delivers similar results to injectable GLP-1 receptor agonists in lowering HbA1c levels and promoting weight loss
What to Avoid While Taking a GLP-1 While no food is strictly forbidden, certain foods can worsen the medications side effects or make it harder to control your blood sugar if you have type 2 diabetes
2 This accords with recommendations that most patients with T2D can receive high-quality care in general practice
Ruggenenti, P., Cattaneo, D., Loriga, G., Ledda, F., Motterlini, N., Gherardi, G., Orisio, S., and Remuzzi, G
An insulin syringe measures in units, where 100 units equals 1mL